Constitutive	O
expression	O
of	O
p50	B-protein
homodimer	I-protein
in	O
freshly	B-cell_type
isolated	I-cell_type
human	I-cell_type
monocytes	I-cell_type
decreases	O
with	O
in	O
vitro	O
and	O
in	O
vivo	O
differentiation	O
:	O
a	O
possible	O
mechanism	O
influencing	O
human	O
immunodeficiency	O
virus	O
replication	O
in	O
monocytes	B-cell_type
and	O
mature	O
macrophages	O
.	O

Human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
replicates	O
more	O
efficiently	O
in	O
vitro	O
in	O
differentiated	B-cell_type
macrophages	I-cell_type
than	O
in	O
freshly	B-cell_type
isolated	I-cell_type
monocytes	I-cell_type
.	O

We	O
investigated	O
whether	O
this	O
may	O
be	O
partly	O
explained	O
by	O
changes	O
in	O
expression	O
of	O
NF-kappaB	B-protein
with	O
monocyte	O
differentiation	O
.	O

We	O
demonstrated	O
that	O
constitutive	O
expression	O
of	O
NF-kappaB	B-protein
in	O
primary	B-cell_type
human	I-cell_type
monocytes	I-cell_type
changed	O
significantly	O
with	O
differentiation	O
in	O
vitro	O
to	O
monocyte-derived	B-cell_type
macrophages	I-cell_type
(	O
MDMs	B-cell_type
)	O
and	O
differentiation	O
in	O
vivo	O
to	O
alveolar	B-cell_type
macrophages	I-cell_type
(	O
AMs	B-cell_type
)	O
.	O

Freshly	O
isolated	O
monocytes	O
constitutively	O
expressed	O
high	O
levels	O
of	O
transcriptionally	B-protein
inactive	I-protein
p50	I-protein
homodimer	I-protein
which	O
decreased	O
with	O
time	O
in	O
culture	O
in	O
favor	O
of	O
the	O
transcriptionally	O
active	O
p50/p65	B-protein
and	I-protein
p50/RelB	I-protein
heterodimers	I-protein
.	O

As	O
in	O
MDMs	B-cell_type
,	O
AMs	B-cell_type
constitutively	O
expressed	O
p50/p65	B-protein
and	O
p50/RelB	B-protein
although	O
at	O
lower	O
levels	O
.	O

HIV	O
infection	O
of	O
fresh	O
monocytes	B-cell_type
failed	O
to	O
induce	O
p50/p65	B-protein
as	O
seen	O
in	O
MDMs	B-cell_type
.	O

The	O
replacement	O
of	O
p50	B-protein
homodimers	I-protein
with	O
transcriptionally	O
active	O
heterodimers	O
following	O
time	O
in	O
culture	O
may	O
partially	O
explain	O
the	O
progressive	O
increase	O
in	O
susceptibility	O
of	O
monocytes	B-cell_type
to	O
HIV	O
infection	O
during	O
in	O
vitro	O
culture	O
.	O

The	O
change	O
in	O
NF-kappaB	B-protein
components	I-protein
with	O
monocyte	O
differentiation	O
in	O
vivo	O
may	O
also	O
explain	O
the	O
different	O
transcriptional	O
activities	O
of	O
these	O
cell	O
populations	O
in	O
HIV-infected	O
individuals	O
.	O

JOURNAL	NULL
OF	NULL
ViroLoGYy	NULL
,	NULL
Mar	NULL
.	NULL

1997	NULL
,	NULL
p.	NULL
2114-2119	NULL
0022-538X	NULL
,	NULL
/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

71	NULL
,	NULL
No	NULL
.	NULL

3	NULL
Constitutive	NULL
Expression	NULL
of	NULL
p50	NULL
Homodimer	NULL
in	NULL
Freshly	NULL
Isolated	NULL
Human	NULL
Monocytes	NULL
Decreases	NULL
with	NULL
In	NULL
Vitro	NULL
and	NULL
In	NULL
Vivo	NULL
Differentiation	NULL
:	NULL
a	NULL
Possible	NULL
Mechanism	NULL
Influencing	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Replication	NULL
in	NULL
Monocytes	NULL
and	NULL
Mature	NULL
Macrophages	NULL
SHARON	NULL
R.	NULL
LEWIN	NULL
,	NULL
PAUL	NULL
LAMBERT	NULL
,	NULL
NICK	NULL
J.	NULL
DEACON	NULL
,	NULL
JOHN	NULL
MILLS	NULL
,	NULL
anp	NULL
SUZANNE	NULL
M.	NULL
CROWE*	NULL
National	NULL
Centre	NULL
for	NULL
HIV	NULL
Virology	NULL
Research	NULL
,	NULL
Macfarlane	NULL
Burnet	NULL
Centre	NULL
for	NULL
Medical	NULL
Research	NULL
,	NULL
Fairfield	NULL
,	NULL
Victoria	NULL
3078	NULL
,	NULL
Australia	NULL
Received	NULL
29	NULL
May	NULL
1996/Accepted	NULL
3	NULL
December	NULL
1996	NULL
Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
replicates	NULL
more	NULL
efficiently	NULL
in	NULL
vitro	NULL
in	NULL
differentiated	NULL
macrophages	NULL
than	NULL
in	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
.	NULL

We	NULL
investigated	NULL
whether	NULL
this	NULL
may	NULL
be	NULL
partly	NULL
explained	NULL
by	NULL
changes	NULL
in	NULL
expression	NULL
of	NULL
NF-KB	NULL
with	NULL
monocyte	NULL
differentiation	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
constitutive	NULL
expression	NULL
of	NULL
NF-KB	NULL
in	NULL
primary	NULL
human	NULL
monocytes	NULL
changed	NULL
significantly	NULL
with	NULL
differentiation	NULL
in	NULL
vitro	NULL
to	NULL
monocyte-derived	NULL
macrophages	NULL
(	NULL
MDMs	NULL
)	NULL
and	NULL
differentiation	NULL
in	NULL
vivo	NULL
to	NULL
alveolar	NULL
macrophages	NULL
(	NULL
AMs	NULL
)	NULL
.	NULL

Freshly	NULL
isolated	NULL
monocytes	NULL
constitutively	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
transcriptionally	NULL
inactive	NULL
p50	NULL
homodimer	NULL
which	NULL
decreased	NULL
with	NULL
time	NULL
in	NULL
culture	NULL
in	NULL
favor	NULL
of	NULL
the	NULL
transcriptionally	NULL
active	NULL
p50/p65	NULL
and	NULL
pS50/ReIB	NULL
heterodimers	NULL
.	NULL

As	NULL
in	NULL
MDMs	NULL
,	NULL
AMs	NULL
constitutively	NULL
expressed	NULL
p50/p65	NULL
and	NULL
p50/ReIB	NULL
although	NULL
at	NULL
lower	NULL
levels	NULL
.	NULL

HIV	NULL
infection	NULL
of	NULL
fresh	NULL
monocytes	NULL
failed	NULL
to	NULL
induce	NULL
p50/p65	NULL
as	NULL
seen	NULL
in	NULL
MDMs	NULL
.	NULL

The	NULL
replacement	NULL
of	NULL
p50	NULL
homodimers	NULL
with	NULL
transcriptionally	NULL
active	NULL
heterodimers	NULL
following	NULL
time	NULL
in	NULL
culture	NULL
may	NULL
partially	NULL
explain	NULL
the	NULL
progressive	NULL
increase	NULL
in	NULL
susceptibility	NULL
of	NULL
monocytes	NULL
to	NULL
HIV	NULL
infection	NULL
during	NULL
in	NULL
vitro	NULL
culture	NULL
.	NULL

The	NULL
change	NULL
in	NULL
NF-	NULL
<	NULL
B	NULL
components	NULL
with	NULL
monocyte	NULL
differentiation	NULL
in	NULL
vivo	NULL
may	NULL
also	NULL
explain	NULL
the	NULL
different	NULL
transcriptional	NULL
activities	NULL
of	NULL
these	NULL
cell	NULL
populations	NULL
in	NULL
HIV	NULL
infected	NULL
individuals	NULL
.	NULL

is	NULL
a	NULL
transcription	NULL
factor	NULL
(	NULL
2	NULL
)	NULL
which	NULL
strongly	NULL
activates	NULL
transcription	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
provi-rus	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
22	NULL
)	NULL
and	NULL
monocytic	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
10	NULL
,	NULL
33	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B/	NULL
Rel	NULL
family	NULL
of	NULL
proteins	NULL
is	NULL
a	NULL
group	NULL
of	NULL
structurally	NULL
and	NULL
functionally	NULL
related	NULL
transcription	NULL
factors	NULL
and	NULL
includes	NULL
p50	NULL
(	NULL
NF-KB1	NULL
)	NULL
,	NULL
p52	NULL
(	NULL
NF-KB2	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
,	NULL
RelB	NULL
,	NULL
and	NULL
c-Rel	NULL
,	NULL
which	NULL
can	NULL
form	NULL
a	NULL
variety	NULL
of	NULL
homo-	NULL
and	NULL
heterodimers	NULL
.	NULL

There	NULL
is	NULL
a	NULL
homologous	NULL
region	NULL
within	NULL
each	NULL
member	NULL
of	NULL
this	NULL
family	NULL
known	NULL
as	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
which	NULL
is	NULL
responsible	NULL
for	NULL
DNA	NULL
binding	NULL
,	NULL
dimerization	NULL
,	NULL
and	NULL
nuclear	NULL
localization	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

The	NULL
carboxyl-terminal	NULL
regions	NULL
of	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
ReIB	NULL
contain	NULL
transcription	NULL
activation	NULL
domains	NULL
(	NULL
3	NULL
,	NULL
26	NULL
,	NULL
34	NULL
)	NULL
,	NULL
while	NULL
p50	NULL
and	NULL
pS2	NULL
lack	NULL
these	NULL
domains	NULL
.	NULL

p50	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
transactivation	NULL
of	NULL
several	NULL
genes	NULL
including	NULL
those	NULL
controlled	NULL
by	NULL
the	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
(	NULL
7	NULL
,	NULL
8	NULL
,	NULL
34	NULL
)	NULL
.	NULL

A	NULL
family	NULL
of	NULL
serine	NULL
proteases	NULL
expressed	NULL
exclusively	NULL
in	NULL
myelomonocytic	NULL
cells	NULL
has	NULL
been	NULL
de-scribed	NULL
,	NULL
which	NULL
cleaves	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
p65	NULL
in	NULL
vitro	NULL
(	NULL
6	NULL
)	NULL
;	NULL
these	NULL
proteases	NULL
may	NULL
explain	NULL
previous	NULL
reports	NULL
of	NULL
novel	NULL
fast-migrating	NULL
NF-	NULL
«	NULL
B-specific	NULL
complexes	NULL
associated	NULL
with	NULL
restricted	NULL
HIV	NULL
expression	NULL
in	NULL
certain	NULL
myelomonocytic	NULL
cells	NULL
(	NULL
23	NULL
,	NULL
27-29	NULL
)	NULL
.	NULL

Monocytes	NULL
and	NULL
macrophages	NULL
differ	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
support	NULL
HIV	NULL
replication	NULL
both	NULL
in	NULL
vitro	NULL
(	NULL
24	NULL
,	NULL
30	NULL
,	NULL
39	NULL
)	NULL
and	NULL
in	NULL
vivo	NULL
(	NULL
16	NULL
,	NULL
37	NULL
)	NULL
.	NULL

In	NULL
general	NULL
,	NULL
HIV	NULL
replication	NULL
in	NULL
monocytes	NULL
appears	NULL
to	NULL
require	NULL
at	NULL
least	NULL
partial	NULL
differentiation	NULL
(	NULL
30	NULL
,	NULL
36	NULL
,	NULL
38	NULL
,	NULL
39	NULL
)	NULL
and	NULL
is	NULL
enhanced	NULL
by	NULL
factors	NULL
that	NULL
promote	NULL
differentiation	NULL
(	NULL
14	NULL
,	NULL
17	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
block	NULL
prior	NULL
to	NULL
the	NULL
initiation	NULL
of	NULL
reverse	NULL
transcription	NULL
has	NULL
been	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Macfarlane	NULL
Burnet	NULL
Centre	NULL
for	NULL
Medical	NULL
Research	NULL
,	NULL
P.O	NULL
.	NULL

Box	NULL
254	NULL
,	NULL
Fairfield	NULL
,	NULL
Victoria	NULL
3078	NULL
Aus-tralia	NULL
.	NULL

Phone	NULL
:	NULL
61	NULL
3	NULL
9280	NULL
2394	NULL
.	NULL

Fax	NULL
:	NULL
61	NULL
3	NULL
9280	NULL
2561	NULL
.	NULL

E-mail	NULL
:	NULL
tolli	NULL
@	NULL
burnet.mbcrr.unimelb.edu.au	NULL
.	NULL

2114	NULL
demonstrated	NULL
to	NULL
occur	NULL
in	NULL
fresh	NULL
monocytes	NULL
.	NULL

However	NULL
,	NULL
reverse	NULL
transcription	NULL
was	NULL
initiated	NULL
if	NULL
the	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
culture	NULL
for	NULL
as	NULL
little	NULL
as	NULL
24	NULL
h	NULL
prior	NULL
to	NULL
infection	NULL
,	NULL
and	NULL
increasing	NULL
the	NULL
time	NULL
in	NULL
culture	NULL
prior	NULL
to	NULL
exposure	NULL
to	NULL
HIV	NULL
resulted	NULL
in	NULL
a	NULL
greater	NULL
percentage	NULL
of	NULL
cells	NULL
infected	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Monocyte-derived	NULL
macrophages	NULL
(	NULL
MDMs	NULL
)	NULL
and	NULL
alveolar	NULL
macrophages	NULL
(	NULL
AMs	NULL
)	NULL
express	NULL
fewer	NULL
surface	NULL
CD4	NULL
receptors	NULL
than	NULL
do	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
(	NULL
19	NULL
,	NULL
24	NULL
,	NULL
39	NULL
)	NULL
but	NULL
are	NULL
more	NULL
susceptible	NULL
to	NULL
infection	NULL
(	NULL
30	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
differences	NULL
following	NULL
HIV	NULL
infection	NULL
of	NULL
fresh	NULL
monocytes	NULL
,	NULL
MDMs	NULL
,	NULL
and	NULL
AMs	NULL
in	NULL
the	NULL
numbers	NULL
of	NULL
initiated	NULL
and	NULL
complete	NULL
viral	NULL
transcripts	NULL
do	NULL
not	NULL
fully	NULL
explain	NULL
the	NULL
relative	NULL
differences	NULL
in	NULL
permissiveness	NULL
to	NULL
infection	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
monocyte	NULL
differentiation	NULL
,	NULL
although	NULL
associated	NULL
with	NULL
changes	NULL
in	NULL
events	NULL
prior	NULL
to	NULL
reverse	NULL
transcription	NULL
,	NULL
may	NULL
also	NULL
involve	NULL
intracellular	NULL
changes	NULL
which	NULL
enhance	NULL
HIV	NULL
replication	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
differentiation	NULL
of	NULL
fresh	NULL
monocytes	NULL
,	NULL
either	NULL
in	NULL
vitro	NULL
or	NULL
in	NULL
vivo	NULL
,	NULL
was	NULL
associated	NULL
with	NULL
significant	NULL
changes	NULL
in	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
NF-kB	NULL
.	NULL

Fresh	NULL
monocytes	NULL
predominantly	NULL
express	NULL
a	NULL
p50	NULL
homodimer	NULL
;	NULL
with	NULL
differentiation	NULL
,	NULL
p50	NULL
homodimer	NULL
expression	NULL
decreases	NULL
and	NULL
is	NULL
replaced	NULL
by	NULL
p50/p65	NULL
and	NULL
p50/ReIB	NULL
heterodimers	NULL
.	NULL

The	NULL
replacement	NULL
of	NULL
p50	NULL
homodimers	NULL
with	NULL
transcriptionally	NULL
active	NULL
heterodimers	NULL
following	NULL
time	NULL
in	NULL
culture	NULL
may	NULL
partially	NULL
explain	NULL
the	NULL
progressive	NULL
increase	NULL
in	NULL
susceptibility	NULL
of	NULL
monocytes	NULL
to	NULL
HIV	NULL
infection	NULL
during	NULL
in	NULL
vitro	NULL
culture	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Nuclear	NULL
extracts	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
high-salt	NULL
extraction	NULL
method	NULL
(	NULL
4a	NULL
)	NULL
using	NULL
some	NULL
modifications	NULL
described	NULL
by	NULL
Bellas	NULL
et	NULL
al	NULL
.	NULL

(	NULL
4	NULL
)	NULL
.	NULL

This	NULL
method	NULL
allowed	NULL
the	NULL
use	NULL
of	NULL
small	NULL
numbers	NULL
of	NULL
cells	NULL
and	NULL
minimized	NULL
proteolysis	NULL
,	NULL
a	NULL
common	NULL
problem	NULL
in	NULL
the	NULL
manipulation	NULL
of	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
to	NULL
10	NULL
%	NULL
10°	NULL
cells	NULL
were	NULL
collected	NULL
,	NULL
washed	NULL
in	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
Cytosys-tems	NULL
,	NULL
Sidney	NULL
,	NULL
Australia	NULL
)	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
2	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
2	NULL
mM	NULL
MgCl	NULL
;	NULL
,	NULL
5	NULL
mM	NULL
KCI	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
,	NULL
which	NULL
was	NULL
then	NULL
Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
adjusted	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
buffer	NULL
A	NULL
plus	NULL
1.0	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

Following	NULL
incubation	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
min	NULL
,	NULL
nuclei	NULL
were	NULL
pelleted	NULL
at	NULL
500	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Nuclei	NULL
were	NULL
extracted	NULL
in	NULL
high-salt	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
7.5	NULL
}	NULL
,	NULL
0.5	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
)	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

All	NULL
buffers	NULL
were	NULL
supplemented	NULL
with	NULL
the	NULL
following	NULL
protease	NULL
inhibitors	NULL
:	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
;	NULL
aprotinin	NULL
,	NULL
0.2	NULL
pg/ml	NULL
;	NULL
leupeptin	NULL
,	NULL
0.5	NULL
pg/ml	NULL
;	NULL
pepstatin	NULL
,	NULL
0.7	NULL
pg/ml	NULL
;	NULL
antipain	NULL
,	NULL
50	NULL
g/ml	NULL
;	NULL
trypsin	NULL
inhibitor	NULL
,	NULL
50	NULL
pg/ml	NULL
;	NULL
and	NULL
chymostatin	NULL
,	NULL
20	NULL
pg/ml	NULL
(	NULL
all	NULL
from	NULL
Bochr-inger	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Cell	NULL
debris	NULL
was	NULL
removed	NULL
by	NULL
centrifu-gation	NULL
at	NULL
13,000	NULL
x	NULL
g	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
dialyzed	NULL
for	NULL
2	NULL
h	NULL
against	NULL
buffer	NULL
B	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
90	NULL
mM	NULL
KCI	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
2	NULL
mM	NULL
PMSF	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

The	NULL
concentrations	NULL
of	NULL
protein	NULL
in	NULL
nuclear	NULL
extract	NULL
samples	NULL
were	NULL
determined	NULL
by	NULL
using	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
as	NULL
the	NULL
standard	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Two	NULL
to	NULL
4	NULL
pg	NULL
of	NULL
protein	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
10°	NULL
cpm	NULL
(	NULL
0.1	NULL
to	NULL
0.5	NULL
ng	NULL
)	NULL
of	NULL
radiolabelled	NULL
double-stranded	NULL
oligonucleotide	NULL
.	NULL

The	NULL
double-stranded	NULL
probes	NULL
were	NULL
end	NULL
filled	NULL
with	NULL
[	NULL
a-*P	NULL
]	NULL
dCTP	NULL
by	NULL
using	NULL
Klenow	NULL
fragment	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

A	NULL
final	NULL
volume	NULL
of	NULL
20	NULL
wl	NULL
contained	NULL
binding	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mg	NULL
of	NULL
BSA	NULL
per	NULL
ml	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
)	NULL
and	NULL
0.1	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

The	NULL
final	NULL
concentration	NULL
of	NULL
NaCl	NULL
was	NULL
60	NULL
mM	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
electrophoresed	NULL
on	NULL
6	NULL
%	NULL
(	NULL
acrylamide/bisacrylamide	NULL
ratio	NULL
,	NULL
29:1	NULL
)	NULL
prerun	NULL
(	NULL
1	NULL
h	NULL
,	NULL
250	NULL
to	NULL
350	NULL
V	NULL
)	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0.25	NULL
%	NULL
TBE	NULL
(	NULL
Tris-borate-EDTA	NULL
)	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

DNA	NULL
binding	NULL
competition	NULL
was	NULL
assessed	NULL
by	NULL
preincubating	NULL
the	NULL
reaction	NULL
mixture	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
,	NULL
with	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
either	NULL
unlabelled	NULL
oligonucleotide	NULL
(	NULL
specific	NULL
competitor	NULL
)	NULL
or	NULL
unlabelled	NULL
oligonucleotide	NULL
in	NULL
which	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
had	NULL
been	NULL
mutated	NULL
(	NULL
nonspecific	NULL
compet-itor	NULL
)	NULL
.	NULL

The	NULL
oligonucleotide	NULL
used	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
corresponded	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sequence	NULL
present	NULL
within	NULL
the	NULL
enhancer	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
5'-TA	NULL
CAAGGGACTTTCCGCTGGGGACTTTCCAGGGAGGCGTG-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
nonspecific	NULL
competitor	NULL
oligonucleotide	NULL
was	NULL
5'-TACAACTCACT	NULL
TTCCGCTGCTCACTTITTCCAGGGAGGCGTG-3	NULL
'	NULL
.	NULL

The	NULL
oligonucleotide	NULL
containing	NULL
an	NULL
Sp1	NULL
binding	NULL
site	NULL
,	NULL
5'-GATCGATCGGGGCGGGGCGATC-3	NULL
'	NULL
,	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Anna	NULL
Peeters	NULL
,	NULL
Macfarlane	NULL
Burnet	NULL
Centre	NULL
for	NULL
Medical	NULL
Research	NULL
,	NULL
Fairfield	NULL
,	NULL
Australia	NULL
)	NULL
was	NULL
end	NULL
labelled	NULL
with	NULL
[	NULL
y-*°P	NULL
]	NULL
dATP	NULL
.	NULL

All	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
model	NULL
381A	NULL
DNA	NULL
Synthesizer	NULL
by	NULL
using	NULL
phosphoramidite	NULL
chemistry	NULL
.	NULL

Antibodies	NULL
.	NULL

The	NULL
antibodies	NULL
used	NULL
in	NULL
the	NULL
supershift	NULL
assays	NULL
included	NULL
mouse	NULL
polyclonal	NULL
anti-p50	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
K.	NULL
P.	NULL
LeClair	NULL
)	NULL
and	NULL
anti-p65	NULL
,	NULL
anti-p52	NULL
,	NULL
anti-c-Rel	NULL
,	NULL
and	NULL
anti-RelB	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Control	NULL
antibodies	NULL
included	NULL
preimmune	NULL
mouse	NULL
and	NULL
rabbit	NULL
immunoglobulin	NULL
G	NULL
(	NULL
Sigma	NULL
Immuno-chemicals	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

.	NULL

Monocytes	NULL
,	NULL
MDMs	NULL
,	NULL
AMs	NULL
,	NULL
and	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

Monocytes	NULL
were	NULL
isolated	NULL
on	NULL
the	NULL
day	NULL
of	NULL
blood	NULL
collection	NULL
from	NULL
HIV-seronegative	NULL
buffy	NULL
packs	NULL
(	NULL
Red	NULL
Cross	NULL
Blood	NULL
Bank	NULL
,	NULL
Melbourne	NULL
,	NULL
Australia	NULL
)	NULL
by	NULL
density	NULL
gradient	NULL
purification	NULL
and	NULL
plastic	NULL
adherence	NULL
as	NULL
detailed	NULL
previously	NULL
(	NULL
5	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Monocyte	NULL
cultures	NULL
were	NULL
90	NULL
%	NULL
+	NULL
3	NULL
%	NULL
monocytes	NULL
as	NULL
determined	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
using	NULL
anti-CD11c	NULL
mono-clonal	NULL
antibody	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
nonadherent	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
are	NULL
referred	NULL
to	NULL
here	NULL
as	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBLs	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
monocytes	NULL
were	NULL
obtained	NULL
from	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMCs	NULL
)	NULL
by	NULL
using	NULL
a	NULL
magnetic	NULL
activated	NULL
cell	NULL
sorter	NULL
(	NULL
MACS	NULL
;	NULL
Miltenyi	NULL
,	NULL
Bergisch	NULL
Gladbach	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

PBMCs	NULL
were	NULL
incubated	NULL
with	NULL
anti-CD3	NULL
and	NULL
CD19	NULL
antibodies	NULL
(	NULL
hybridomas	NULL
OKT3	NULL
and	NULL
FMC63	NULL
)	NULL
and	NULL
goat	NULL
anti-mouse	NULL
antibody	NULL
bound	NULL
to	NULL
magnetic	NULL
beads	NULL
(	NULL
Miltenyi	NULL
)	NULL
.	NULL

These	NULL
monocytes	NULL
contained	NULL
only	NULL
2	NULL
to	NULL
3	NULL
%	NULL
CD3-	NULL
or	NULL
CD19-positive	NULL
cells	NULL
as	NULL
assessed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

MDMs	NULL
were	NULL
cultured	NULL
in	NULL
polytetrafluoroethylene	NULL
Teflon	NULL
pots	NULL
(	NULL
Saville	NULL
,	NULL
Minnetonka	NULL
,	NULL
Minn.	NULL
)	NULL
and	NULL
harvested	NULL
after	NULL
5	NULL
to	NULL
7	NULL
days	NULL
in	NULL
suspension	NULL
culture	NULL
.	NULL

AMs	NULL
were	NULL
obtained	NULL
from	NULL
bronchoalveolar	NULL
lavage	NULL
from	NULL
healthy	NULL
donors	NULL
who	NULL
gave	NULL
informed	NULL
consent	NULL
(	NULL
as	NULL
approved	NULL
by	NULL
our	NULL
institution	NULL
's	NULL
Human	NULL
Ethics	NULL
Commit-tee	NULL
)	NULL
.	NULL

AMs	NULL
were	NULL
obtained	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
19	NULL
)	NULL
.	NULL

They	NULL
were	NULL
then	NULL
purified	NULL
by	NULL
cither	NULL
adherence	NULL
or	NULL
immunomagnetic	NULL
bead	NULL
selection	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Nuclear	NULL
extraction	NULL
was	NULL
performed	NULL
on	NULL
the	NULL
day	NULL
of	NULL
isolation	NULL
.	NULL

RCZA	NULL
monocytic	NULL
cells	NULL
(	NULL
kind	NULL
gift	NULL
from	NULL
W.	NULL
Boyle	NULL
,	NULL
University	NULL
of	NULL
Melbourne	NULL
,	NULL
Melbourne	NULL
,	NULL
Australia	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Flow	NULL
Laboratories	NULL
)	NULL
.	NULL

All	NULL
solutions	NULL
and	NULL
media	NULL
used	NULL
in	NULL
purification	NULL
and	NULL
culture	NULL
were	NULL
endotoxin	NULL
free	NULL
as	NULL
assessed	NULL
by	NULL
a	NULL
chromogenic	NULL
Limulus	NULL
amoebocyte	NULL
lysate	NULL
assay	NULL
(	NULL
Whittaker	NULL
Bio-products	NULL
,	NULL
Walkersville	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

.	NULL

In	NULL
experiments	NULL
assessing	NULL
the	NULL
response	NULL
to	NULL
lipopoly-saccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
0.1	NULL
mg	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
was	NULL
added	NULL
to	NULL
fresh	NULL
monocytes	NULL
and	NULL
MDMs	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
harvested	NULL
4	NULL
h	NULL
later	NULL
.	NULL

Protein	NULL
electrophoresis	NULL
.	NULL

Protein	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
was	NULL
denatured	NULL
in	NULL
2-mercaptocthanol	NULL
at	NULL
100°C	NULL
for	NULL
2	NULL
min	NULL
and	NULL
run	NULL
on	NULL
sodium	NULL
dodecyl	NULL
sulfate-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
at	NULL
150	NULL
V	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
gel	NULL
was	NULL
fixed	NULL
with	NULL
methanol-glacial	NULL
acetic	NULL
acid	NULL
and	NULL
stained	NULL
with	NULL
Coomassie	NULL
brilliant	NULL
blue	NULL
(	NULL
Bio-Rad	NULL
)	NULL
overnight	NULL
.	NULL

HIV	NULL
infection	NULL
.	NULL

Fresh	NULL
monocytes	NULL
and	NULL
MDMs	NULL
were	NULL
infected	NULL
with	NULL
HIV	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
isolate	NULL
HIV-1p	NULL
,	NULL
1	NULL
,	NULL
(	NULL
9	NULL
)	NULL
or	NULL
a	NULL
primary	NULL
macrophage-tropic	NULL
patient	NULL
isolate	NULL
HIV-147	NULL
,	NULL
(	NULL
kindly	NULL
donated	NULL
by	NULL
Dale	NULL
McPhee	NULL
,	NULL
Macfarlane	NULL
Burnet	NULL
Centre	NULL
for	NULL
Medical	NULL
Research	NULL
)	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
0.01	NULL
(	NULL
as	NULL
assessed	NULL
by	NULL
end	NULL
point	NULL
titration	NULL
in	NULL
MDMs	NULL
)	NULL
.	NULL

Virus	NULL
stock	NULL
suspensions	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
single	NULL
passage	NULL
of	NULL
HIV-15	NULL
,	NULL
4	NULL
,	NULL
through	NULL
MDMs	NULL
followed	NULL
by	NULL
a	NULL
single	NULL
amplification	NULL
in	NULL
PBMCs	NULL
.	NULL

The	NULL
primary	NULL
isolate	NULL
HIV-157	NULL
,	NULL
had	NULL
been	NULL
passaged	NULL
through	NULL
PBMCs	NULL
no	NULL
more	NULL
than	NULL
three	NULL
times	NULL
.	NULL

HIV-1	NULL
virus	NULL
stocks	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
U	NULL
of	NULL
RNase-free	NULL
DNase	NULL
(	NULL
Boe-	NULL
EXPRESSION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
IN	NULL
FRESH	NULL
MONOCYTES	NULL
AND	NULL
MACROPHAGES	NULL
-	NULL
2115	NULL
FM	NULL
PBLs	NULL
MDM	NULL
s	NULL
sC	NULL
-is	NULL
!	NULL

alia	NULL
)	NULL
)	NULL
7	NULL
NSC	NULL
--	NULL
+	NULL
)	NULL
IL	NULL
1	NULL
8	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
fresh	NULL
monocytes	NULL
(	NULL
FM	NULL
)	NULL
,	NULL
PBLs	NULL
,	NULL
and	NULL
MDMs	NULL
contain	NULL
distinctive	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
(	NULL
2	NULL
to	NULL
4	NULL
pug/lane	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
fresh	NULL
monocytes	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
,	NULL
PBLs	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
,	NULL
and	NULL
MDMs	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
with	NULL
the	NULL
radiolabelled	NULL
probe	NULL
alone	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
a	NULL
specific	NULL
competitor	NULL
(	NULL
SC	NULL
)	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
)	NULL
or	NULL
a	NULL
nonspecific	NULL
competitor	NULL
(	NULL
NSC	NULL
)	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

A	NULL
fast-migrating	NULL
complex	NULL
(	NULL
[	NULL
>	NULL
)	NULL
is	NULL
observed	NULL
in	NULL
abundance	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
fresh	NULL
monocytes	NULL
,	NULL
while	NULL
a	NULL
slower-migrating	NULL
doublet	NULL
(	NULL
)	NULL
is	NULL
observed	NULL
in	NULL
those	NULL
from	NULL
MDMs	NULL
.	NULL

hringer-Mannheim	NULL
)	NULL
per	NULL
ml	NULL
and	NULL
10	NULL
mM	NULL
MgCl	NULL
,	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
passed	NULL
through	NULL
a	NULL
0.20-pm-pore-size	NULL
filter	NULL
prior	NULL
to	NULL
use	NULL
in	NULL
experiments	NULL
.	NULL

Control	NULL
cultures	NULL
were	NULL
mock	NULL
infected	NULL
with	NULL
supernatant	NULL
that	NULL
had	NULL
been	NULL
prepared	NULL
in	NULL
parallel	NULL
with	NULL
virus	NULL
amplification	NULL
by	NULL
using	NULL
the	NULL
same	NULL
donor	NULL
PBMCs	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
pulsed	NULL
with	NULL
virus	NULL
or	NULL
mock	NULL
supernatant	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37°C	NULL
and	NULL
then	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
collected	NULL
24	NULL
h	NULL
later	NULL
for	NULL
nuclear	NULL
extraction	NULL
.	NULL

At	NULL
the	NULL
same	NULL
time	NULL
,	NULL
10°	NULL
cells	NULL
were	NULL
lysed	NULL
,	NULL
heated	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
PCR	NULL
amplification	NULL
using	NULL
primers	NULL
to	NULL
gag	NULL
(	NULL
SK38	NULL
and	NULL
SK39	NULL
)	NULL
and	NULL
HLA-DQ	NULL
(	NULL
GH26	NULL
and	NULL
GH27	NULL
)	NULL
as	NULL
previously	NULL
published	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
105	NULL
per	NULL
well	NULL
)	NULL
were	NULL
allowed	NULL
to	NULL
adhere	NULL
to	NULL
a	NULL
24-well	NULL
plate	NULL
(	NULL
Costar	NULL
)	NULL
,	NULL
and	NULL
supernatant	NULL
was	NULL
collected	NULL
at	NULL
days	NULL
7	NULL
and	NULL
14.	NULL
p24	NULL
antigen	NULL
was	NULL
assessed	NULL
by	NULL
using	NULL
the	NULL
Abbot	NULL
p24	NULL
antigen	NULL
quantitation	NULL
kit	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

RESULTS	NULL
Freshly	NULL
isolated	NULL
monocytes	NULL
constitutively	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
a	NULL
fast-migrating	NULL
NF-KB	NULL
complex	NULL
.	NULL

EMSA	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
,	NULL
unstimulated	NULL
PBLs	NULL
,	NULL
and	NULL
MDMs	NULL
showed	NULL
that	NULL
specific	NULL
NF-kB	NULL
complexes	NULL
differed	NULL
in	NULL
these	NULL
cell	NULL
populations	NULL
.	NULL

An	NULL
abundant	NULL
fast-migrating	NULL
complex	NULL
was	NULL
observed	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
,	NULL
while	NULL
the	NULL
predominant	NULL
complex	NULL
in	NULL
MDM	NULL
extracts	NULL
migrated	NULL
more	NULL
slowly	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
the	NULL
fast-migrating	NULL
complex	NULL
did	NULL
not	NULL
alter	NULL
with	NULL
different	NULL
methods	NULL
of	NULL
monocyte	NULL
purification	NULL
,	NULL
either	NULL
adherence	NULL
or	NULL
magnetic	NULL
bead	NULL
negative	NULL
selection	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
fast-migrating	NULL
complex	NULL
persisted	NULL
even	NULL
when	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
chymostatin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
constitutively	NULL
expressed	NULL
,	NULL
slow-migrating	NULL
NF-kB	NULL
were	NULL
observed	NULL
in	NULL
unstimulated	NULL
PBLs	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

2116	NULL
LEWIN	NULL
ET	NULL
AL	NULL
.	NULL

fresh	NULL
monocytes	NULL
SC	NULL
o	NULL
NSC	NULL
rl	NULL
U	NULL
anti	NULL
p50	NULL
!	NULL
}	NULL

!	NULL

sl	NULL
M	NULL
anti	NULL
p65	NULL
=	NULL
>	NULL
)	NULL
;	NULL
M	NULL
anti	NULL
c-Rel	NULL
oe	NULL
.	NULL

W	NULL
T	NULL
.	NULL

ﬂ	NULL
|	NULL
Nun	NULL
“	NULL
!	NULL

|	NULL
V	NULL
I9	NULL
T	NULL
]	NULL
tiate	NULL
.	NULL

8	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

EMSA	NULL
and	NULL
supershift	NULL
analysis	NULL
on	NULL
nuclear	NULL
extracts	NULL
from	NULL
fresh	NULL
monocytes	NULL
(	NULL
2	NULL
to	NULL
4	NULL
pg/lane	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
probe	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
a	NULL
specific	NULL
competitor	NULL
(	NULL
SC	NULL
)	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
a	NULL
nonspecific	NULL
competitor	NULL
(	NULL
NSC	NULL
)	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Antibodies	NULL
used	NULL
included	NULL
antibodies	NULL
to	NULL
p50	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
Jane	NULL
5	NULL
)	NULL
,	NULL
and	NULL
c-Rel	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
control	NULL
antibodies	NULL
were	NULL
mouse	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
and	NULL
rabbit	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
preimmune	NULL
sera	NULL
.	NULL

Symbols	NULL
:	NULL
P	NULL
,	NULL
p50/p65	NULL
heterodimer	NULL
;	NULL
[	NULL
>	NULL
,	NULL
p30	NULL
homodimer	NULL
.	NULL

Freshly	NULL
isolated	NULL
monocytes	NULL
constitutively	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
p50	NULL
homodimer	NULL
,	NULL
while	NULL
MDMs	NULL
constitutively	NULL
express	NULL
p50/	NULL
p65	NULL
and	NULL
pS50/ReIB	NULL
heterodimers	NULL
.	NULL

The	NULL
fast-migrating	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
in	NULL
fresh	NULL
monocytes	NULL
was	NULL
supershifted	NULL
by	NULL
antibodies	NULL
to	NULL
p50	NULL
but	NULL
not	NULL
by	NULL
antibodies	NULL
to	NULL
p65	NULL
or	NULL
c-Rel	NULL
,	NULL
or	NULL
by	NULL
mouse	NULL
or	NULL
rabbit	NULL
preimmune	NULL
sera	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
or	NULL
by	NULL
antibodies	NULL
to	NULL
p52	NULL
or	NULL
ReIB	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
fast-migrating	NULL
complex	NULL
was	NULL
a	NULL
p50	NULL
homodimer	NULL
.	NULL

Because	NULL
the	NULL
p65	NULL
antibody	NULL
used	NULL
was	NULL
directed	NULL
against	NULL
the	NULL
N	NULL
terminus	NULL
and	NULL
failed	NULL
to	NULL
shift	NULL
the	NULL
fast-migrating	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
this	NULL
complex	NULL
did	NULL
not	NULL
contain	NULL
p65	NULL
truncated	NULL
at	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
as	NULL
previously	NULL
reported	NULL
for	NULL
monocytic	NULL
cell	NULL
lines	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
slower-migrating	NULL
complex	NULL
in	NULL
fresh	NULL
monocytes	NULL
was	NULL
a	NULL
doublet	NULL
.	NULL

The	NULL
upper	NULL
band	NULL
was	NULL
supershifted	NULL
by	NULL
antibodies	NULL
to	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
consists	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
while	NULL
the	NULL
lower	NULL
band	NULL
was	NULL
supershifted	NULL
by	NULL
antibodies	NULL
to	NULL
p50	NULL
and	NULL
RelB	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
slower-migrating	NULL
complex	NULL
in	NULL
MDMs	NULL
was	NULL
a	NULL
doublet	NULL
,	NULL
with	NULL
the	NULL
upper	NULL
band	NULL
supershifted	NULL
by	NULL
antibodies	NULL
to	NULL
p50	NULL
and	NULL
p65	NULL
and	NULL
the	NULL
lower	NULL
band	NULL
supershifted	NULL
by	NULL
antibodies	NULL
to	NULL
p50	NULL
and	NULL
RelB	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
doublet	NULL
disappeared	NULL
when	NULL
nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
antibodies	NULL
to	NULL
both	NULL
p65	NULL
and	NULL
RelB	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
p50	NULL
homodimer	NULL
decreases	NULL
with	NULL
differentiation	NULL
in	NULL
vitro	NULL
to	NULL
MDMs	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
monocyte	NULL
cultures	NULL
from	NULL
the	NULL
same	NULL
donor	NULL
were	NULL
taken	NULL
immediately	NULL
postisolation	NULL
and	NULL
then	NULL
following	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
6	NULL
days	NULL
in	NULL
suspension	NULL
culture	NULL
.	NULL

A	NULL
progressive	NULL
reduction	NULL
in	NULL
the	NULL
relative	NULL
amount	NULL
of	NULL
the	NULL
J.	NULL
ViRoL	NULL
.	NULL

monocyte	NULL
derived	NULL
macrophages	NULL
anti	NULL
p50	NULL
eo	NULL
80g	NULL
>	NULL
anti	NULL
p65	NULL
=o	NULL
-	NULL
-	NULL
0	NULL
#	NULL
>	NULL
anti	NULL
RelB	NULL
-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
anti	NULL
c-Rel	NULL
_	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
ll	NULL
“	NULL
A	NULL
‘	NULL
A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Supershift	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
MDMs	NULL
(	NULL
2	NULL
to	NULL
4	NULL
pg/lane	NULL
)	NULL
.	NULL

Antibodies	NULL
used	NULL
included	NULL
antibodies	NULL
to	NULL
p50	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
ReIB	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
p65	NULL
together	NULL
with	NULL
ReIB	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
c-Rel	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Symbols	NULL
:	NULL
P	NULL
»	NULL
,	NULL
p50/p65	NULL
heterodimer	NULL
;	NULL
@	NULL
,	NULL
p50/ReIB	NULL
heterodimer	NULL
;	NULL
[	NULL
>	NULL
,	NULL
p50	NULL
homodimer	NULL
.	NULL

fast-migrating	NULL
p50	NULL
homodimer	NULL
complex	NULL
was	NULL
observed	NULL
with	NULL
time	NULL
in	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
complex	NULL
was	NULL
demonstrated	NULL
in	NULL
previous	NULL
experiments	NULL
by	NULL
specific	NULL
and	NULL
nonspecific	NULL
competition	NULL
(	NULL
r	NULL
=	NULL
6	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

monocyte/MDM	NULL
day	NULL
of	NULL
extraction	NULL
-	NULL
O0	NULL
1	NULL
3	NULL
6	NULL
V	NULL
¥	NULL
RAUVTT	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
monocytes	NULL
taken	NULL
on	NULL
the	NULL
day	NULL
of	NULL
isolation	NULL
(	NULL
-	NULL
)	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
following	NULL
1	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
3	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
6	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
days	NULL
in	NULL
culture	NULL
(	NULL
2	NULL
to	NULL
4	NULL
ug/lane	NULL
)	NULL
.	NULL

Symbols	NULL
:	NULL
P	NULL
,	NULL
p50/p65	NULL
heterodimer	NULL
;	NULL
[	NULL
>	NULL
,	NULL
p50	NULL
homodimer	NULL
.	NULL

Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
alveolar	NULL
macrophages	NULL
anti	NULL
p50	NULL
ter-	NULL
!	NULL

anti	NULL
p65	NULL
i	NULL
;	NULL
I	NULL
anti	NULL
c-Rel	NULL
U	NULL
anti	NULL
RelB	NULL
ener-	NULL
!	NULL

=	NULL
>	NULL
U	NULL
anti	NULL
p52	NULL
sa-l.	NULL
)	NULL
;	NULL
U	NULL
»	NULL
|	NULL
w	NULL
``	NULL
I	NULL
``	NULL
©	NULL
-im	NULL
+	NULL
e	NULL
talc	NULL
!	NULL

~	NULL
'	NULL
``	NULL
83	NULL
)	NULL
2	NULL
,	NULL
18	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Supershift	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
AMs	NULL
demonstrate	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
pS0/p65	NULL
and	NULL
pS0/ReIB	NULL
(	NULL
5	NULL
to	NULL
10	NULL
pg/lane	NULL
)	NULL
.	NULL

EMSA	NULL
is	NULL
shown	NULL
with	NULL
the	NULL
radiolabelled	NULL
probe	NULL
alone	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
antibodies	NULL
to	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
RelB	NULL
,	NULL
p52	NULL
,	NULL
or	NULL
both	NULL
p52	NULL
and	NULL
RelB	NULL
.	NULL

Control	NULL
antibodies	NULL
included	NULL
mouse	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
and	NULL
rabbit	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
preimmune	NULL
sera	NULL
.	NULL

Symbols	NULL
:	NULL
P	NULL
»	NULL
,	NULL
p50/p65	NULL
heterodimer	NULL
;	NULL
@	NULL
,	NULL
p50/ReIB	NULL
heterodimer	NULL
;	NULL
-	NULL
&	NULL
»	NULL
,	NULL
p50/p65	NULL
breakdown	NULL
product	NULL
.	NULL

EXPRESSION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
IN	NULL
FRESH	NULL
MONOCYTES	NULL
AND	NULL
MACROPHAGES	NULL
2117	NULL
Human	NULL
AMs	NULL
constitutively	NULL
express	NULL
low	NULL
levels	NULL
of	NULL
p50/p65	NULL
and	NULL
p50/ReIB	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
AMs	NULL
analyzed	NULL
by	NULL
EMSA	NULL
revealed	NULL
a	NULL
doublet	NULL
which	NULL
was	NULL
specific	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
as	NULL
demonstrated	NULL
by	NULL
specific	NULL
and	NULL
nonspecific	NULL
competition	NULL
experiments	NULL
using	NULL
the	NULL
oligonucleotides	NULL
noted	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
upper	NULL
band	NULL
supershifted	NULL
by	NULL
antibodies	NULL
to	NULL
both	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
and	NULL
the	NULL
lower	NULL
band	NULL
supershifted	NULL
by	NULL
antibodies	NULL
to	NULL
p50	NULL
and	NULL
RelB	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
supershift	NULL
is	NULL
best	NULL
demonstrated	NULL
when	NULL
both	NULL
p65	NULL
and	NULL
RelB	NULL
are	NULL
incubated	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
together	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
expression	NULL
were	NULL
observed	NULL
despite	NULL
high	NULL
levels	NULL
of	NULL
extracted	NULL
nuclear	NULL
protein	NULL
(	NULL
5	NULL
to	NULL
10	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
per	NULL
lane	NULL
)	NULL
.	NULL

A	NULL
small	NULL
amount	NULL
of	NULL
degradation	NULL
of	NULL
p50/p65	NULL
was	NULL
observed	NULL
as	NULL
a	NULL
fast-migrating	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
that	NULL
shifted	NULL
with	NULL
both	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

This	NULL
was	NULL
observed	NULL
in	NULL
only	NULL
one	NULL
of	NULL
three	NULL
AM	NULL
nuclear	NULL
extracts	NULL
.	NULL

Coomassie	NULL
brilliant	NULL
blue	NULL
staining	NULL
of	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis-resolved	NULL
nuclear	NULL
extracts	NULL
from	NULL
AMs	NULL
,	NULL
fresh	NULL
monocytes	NULL
,	NULL
and	NULL
a	NULL
differentiated	NULL
monocytic	NULL
cell	NULL
line	NULL
,	NULL
RC2A	NULL
,	NULL
revealed	NULL
a	NULL
similar	NULL
banding	NULL
pattern	NULL
without	NULL
nonspecific	NULL
smearing	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
reduced	NULL
levels	NULL
of	NULL
NF-kB	NULL
in	NULL
AM	NULL
were	NULL
not	NULL
a	NULL
consequence	NULL
of	NULL
a	NULL
generalized	NULL
protein	NULL
degradation	NULL
by	NULL
cellular	NULL
proteases	NULL
occurring	NULL
during	NULL
nuclear	NULL
extraction	NULL
.	NULL

EMSA	NULL
with	NULL
a	NULL
radioactively	NULL
labelled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
Sp1	NULL
binding	NULL
site	NULL
showed	NULL
that	NULL
AMs	NULL
had	NULL
a	NULL
binding	NULL
pattern	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
RCZA	NULL
cell	NULL
line	NULL
but	NULL
markedly	NULL
reduced	NULL
in	NULL
intensity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
infection	NULL
by	NULL
HIV-l-induced	NULL
p50	NULL
homodimer	NULL
and	NULL
p50/p65	NULL
in	NULL
MDMs	NULL
but	NULL
not	NULL
in	NULL
fresh	NULL
monocytes	NULL
.	NULL

In	NULL
vitro	NULL
infection	NULL
of	NULL
MDM	NULL
with	NULL
the	NULL
macrophage-tropic	NULL
laboratory	NULL
isolate	NULL
HIV-1	NULL
»	NULL
;	NULL
,	NULL
;	NULL
,	NULL
induced	NULL
p50	NULL
homodimer	NULL
and	NULL
p50/p65	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
20	NULL
,	NULL
40	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
vitro	NULL
infection	NULL
of	NULL
fresh	NULL
monocytes	NULL
with	NULL
HIV-1	NULL
;	NULL
;	NULL
,	NULL
;	NULL
,	NULL
and	NULL
a	NULL
low-passage	NULL
,	NULL
macrophage-tropic	NULL
primary	NULL
isolate	NULL
HIV-1	NULL
;	NULL
;	NULL
,	NULL
failed	NULL
to	NULL
induce	NULL
p50/p65	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

These	NULL
nuclear	NULL
extracts	NULL
were	NULL
taken	NULL
following	NULL
24	NULL
h	NULL
in	NULL
culture	NULL
,	NULL
which	NULL
may	NULL
explain	NULL
the	NULL
lower	NULL
relative	NULL
amount	NULL
of	NULL
p50	NULL
homodimer	NULL
seen	NULL
for	NULL
the	NULL
fresh	NULL
monocytes	NULL
than	NULL
that	NULL
seen	NULL
in	NULL
previous	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Fresh	NULL
monocytes	NULL
are	NULL
less	NULL
permissive	NULL
to	NULL
in	NULL
vitro	NULL
HIV-1	NULL
A	NULL
monocytes	NULL
MDM	NULL
mock	NULL
HIV—1Ba-L	NULL
H|V-1676	NULL
mock	NULL
HIV'1Ba—L	NULL
anti	NULL
p50	NULL
-	NULL
+	NULL
-	NULL
no	NULL
#	NULL
09	NULL
0	NULL
no	NULL
¥	NULL
of	NULL
~-	NULL
#	NULL
no	NULL
#	NULL
s-anti	NULL
p6§	NULL
-	NULL
ct	NULL
+0	NULL
c	NULL
ot	NULL
+	NULL
oto	NULL
oto	NULL
o	NULL
#	NULL
to	NULL
t	NULL
to	NULL
c	NULL
o	NULL
o+	NULL
ia	NULL
B	NULL
8E5	NULL
cell	NULL
line	NULL
monocytes	NULL
DQ	NULL
-m	NULL
tts	NULL
coe	NULL
-	NULL
W	NULL
Wh	NULL
a	NULL
I	NULL
p	NULL
°	NULL
E	NULL
D	NULL
‘	NULL
J	NULL
gag	NULL
-m	NULL
Alls	NULL
»	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
l	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

(	NULL
A	NULL
)	NULL
p50/p65	NULL
heterodimers	NULL
are	NULL
induced	NULL
with	NULL
HIV-1	NULL
infection	NULL
of	NULL
MDMs	NULL
,	NULL
but	NULL
induction	NULL
does	NULL
not	NULL
occur	NULL
with	NULL
HIV-1	NULL
infection	NULL
of	NULL
fresh	NULL
monocytes	NULL
.	NULL

EMSA	NULL
were	NULL
done	NULL
with	NULL
fresh	NULL
monocytes	NULL
and	NULL
MDMs	NULL
incubated	NULL
with	NULL
mock	NULL
supernatant	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
and	NULL
10	NULL
to	NULL
12	NULL
)	NULL
or	NULL
infected	NULL
with	NULL
,	NULL
_	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
and	NULL
13	NULL
to	NULL
15	NULL
)	NULL
or	NULL
HIV-157	NULL
,	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
.	NULL

Supershift	NULL
analyses	NULL
were	NULL
done	NULL
with	NULL
antibodies	NULL
to	NULL
p50	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
8	NULL
,	NULL
11	NULL
,	NULL
and	NULL
14	NULL
)	NULL
and	NULL
p65	NULL
(	NULL
lane	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
and	NULL
15	NULL
)	NULL
.	NULL

Symbols	NULL
:	NULL
,	NULL
p50/p65	NULL
heterodimer	NULL
;	NULL
[	NULL
>	NULL
,	NULL
p50	NULL
homodimer	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Autoradiograph	NULL
of	NULL
radiolabelled	NULL
products	NULL
from	NULL
PCR	NULL
amplification	NULL
of	NULL
extracts	NULL
from	NULL
fresh	NULL
monocytes	NULL
that	NULL
were	NULL
mock	NULL
infected	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
HIV-13	NULL
,	NULL
,	NULL
,	NULL
(	NULL
Jane	NULL
8	NULL
)	NULL
or	NULL
HIV-147	NULL
,	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
and	NULL
8E5	NULL
cell	NULL
extracts	NULL
with	NULL
the	NULL
equivalent	NULL
of	NULL
10°	NULL
,	NULL
10	NULL
%	NULL
,	NULL
10°	NULL
,	NULL
10	NULL
%	NULL
,	NULL
10	NULL
%	NULL
,	NULL
and	NULL
10°	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
6	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

-	NULL
,	NULL
control	NULL
(	NULL
no	NULL
DNA	NULL
}	NULL
.	NULL

2118	NULL
LEWIN	NULL
ET	NULL
AL	NULL
.	NULL

infection	NULL
than	NULL
MDMs	NULL
(	NULL
39	NULL
)	NULL
,	NULL
but	NULL
although	NULL
no	NULL
gag	NULL
proviral	NULL
DNA	NULL
was	NULL
seen	NULL
at	NULL
the	NULL
time	NULL
of	NULL
nuclear	NULL
extraction	NULL
,	NULL
24	NULL
h	NULL
postinfection	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
,	NULL
low-level	NULL
infection	NULL
of	NULL
fresh	NULL
monocytes	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
p24	NULL
antigen	NULL
in	NULL
culture	NULL
supernatant	NULL
taken	NULL
7	NULL
days	NULL
postinfection	NULL
.	NULL

The	NULL
mean	NULL
p24	NULL
level	NULL
7	NULL
days	NULL
following	NULL
infection	NULL
with	NULL
;	NULL
,	NULL
of	NULL
fresh	NULL
monocytes	NULL
was	NULL
719	NULL
pg/ml	NULL
(	NULL
range	NULL
,	NULL
97	NULL
to	NULL
2,094	NULL
pg/ml	NULL
;	NULL
r	NULL
»	NULL
=	NULL
5	NULL
)	NULL
,	NULL
and	NULL
following	NULL
infection	NULL
of	NULL
MDMs	NULL
,	NULL
it	NULL
was	NULL
4,862	NULL
pg/ml	NULL
(	NULL
range	NULL
,	NULL
642	NULL
to	NULL
8,845	NULL
pg/ml	NULL
;	NULL
n	NULL
=	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
found	NULL
that	NULL
LPS	NULL
induced	NULL
p50/p65	NULL
expression	NULL
in	NULL
fresh	NULL
monocytes	NULL
but	NULL
not	NULL
in	NULL
MDMs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
This	NULL
study	NULL
demonstrates	NULL
that	NULL
fresh	NULL
monocytes	NULL
,	NULL
macrophages	NULL
derived	NULL
from	NULL
monocytes	NULL
by	NULL
in	NULL
vitro	NULL
culture	NULL
(	NULL
MDMs	NULL
)	NULL
and	NULL
AMs	NULL
each	NULL
have	NULL
a	NULL
distinctive	NULL
pattern	NULL
of	NULL
constitutive	NULL
expression	NULL
of	NULL
NF-kB	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
analysis	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
in	NULL
primary	NULL
differentiated	NULL
human	NULL
macrophages	NULL
,	NULL
namely	NULL
,	NULL
in	NULL
AMs	NULL
.	NULL

In	NULL
fresh	NULL
monocytes	NULL
,	NULL
the	NULL
predominant	NULL
NF-	NULL
«	NULL
B	NULL
species	NULL
expressed	NULL
is	NULL
p50	NULL
homodimer	NULL
,	NULL
while	NULL
the	NULL
predominant	NULL
species	NULL
expressed	NULL
in	NULL
macrophages	NULL
which	NULL
have	NULL
differentiated	NULL
in	NULL
vitro	NULL
(	NULL
MDM	NULL
)	NULL
or	NULL
in	NULL
vivo	NULL
(	NULL
AM	NULL
)	NULL
are	NULL
p50/p65	NULL
and	NULL
p50/ReIB	NULL
.	NULL

Furthermore	NULL
,	NULL
as	NULL
fresh	NULL
monocytes	NULL
differentiate	NULL
in	NULL
vitro	NULL
,	NULL
there	NULL
is	NULL
a	NULL
progressive	NULL
loss	NULL
of	NULL
p50	NULL
homodimer	NULL
,	NULL
altering	NULL
the	NULL
balance	NULL
in	NULL
favor	NULL
of	NULL
p50/p65	NULL
and	NULL
p5S0/ReIB	NULL
.	NULL

Our	NULL
findings	NULL
of	NULL
a	NULL
predominant	NULL
p50	NULL
homodimer	NULL
in	NULL
fresh	NULL
monocytes	NULL
and	NULL
the	NULL
replacement	NULL
of	NULL
this	NULL
homodimer	NULL
by	NULL
p50/p65	NULL
and	NULL
p50/ReIB	NULL
may	NULL
explain	NULL
the	NULL
progressive	NULL
increase	NULL
in	NULL
susceptibility	NULL
to	NULL
HIV	NULL
infection	NULL
these	NULL
cells	NULL
undergo	NULL
during	NULL
differentiation	NULL
(	NULL
30	NULL
,	NULL
39	NULL
)	NULL
.	NULL

The	NULL
p50	NULL
homodimer	NULL
has	NULL
DNA	NULL
binding	NULL
activity	NULL
but	NULL
is	NULL
thought	NULL
,	NULL
under	NULL
most	NULL
circumstances	NULL
,	NULL
to	NULL
be	NULL
transcriptionally	NULL
inactive	NULL
and	NULL
possibly	NULL
inhibitory	NULL
to	NULL
transactivation	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
8	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
the	NULL
block	NULL
in	NULL
HIV	NULL
replication	NULL
in	NULL
fresh	NULL
monocytes	NULL
is	NULL
prior	NULL
to	NULL
reverse	NULL
transcription	NULL
(	NULL
38	NULL
)	NULL
,	NULL
this	NULL
block	NULL
is	NULL
in	NULL
fact	NULL
overcome	NULL
when	NULL
monocytes	NULL
are	NULL
cultured	NULL
for	NULL
only	NULL
24	NULL
h	NULL
prior	NULL
to	NULL
HIV	NULL
infection	NULL
,	NULL
and	NULL
a	NULL
progressive	NULL
increase	NULL
in	NULL
permissiveness	NULL
to	NULL
infection	NULL
is	NULL
observed	NULL
with	NULL
subsequent	NULL
time	NULL
in	NULL
culture	NULL
(	NULL
36	NULL
,	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
a	NULL
block	NULL
to	NULL
proviral	NULL
transcription	NULL
could	NULL
further	NULL
and	NULL
independently	NULL
modulate	NULL
replication	NULL
of	NULL
the	NULL
HIV	NULL
particles	NULL
that	NULL
manage	NULL
to	NULL
enter	NULL
and	NULL
integrate	NULL
into	NULL
the	NULL
host	NULL
genome	NULL
in	NULL
monocytes	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
or	NULL
more	NULL
.	NULL

Our	NULL
experiments	NULL
show	NULL
that	NULL
nuclear	NULL
extracts	NULL
from	NULL
fresh	NULL
monocytes	NULL
contained	NULL
chiefly	NULL
p50	NULL
homodimer	NULL
with	NULL
small	NULL
amounts	NULL
of	NULL
p50/p65	NULL
and	NULL
p50/ReIB	NULL
heterodimers	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
some	NULL
monocytic	NULL
cell	NULL
extracts	NULL
contain	NULL
a	NULL
form	NULL
of	NULL
p50/p65	NULL
in	NULL
which	NULL
p65	NULL
has	NULL
been	NULL
truncated	NULL
at	NULL
the	NULL
C	NULL
terminus	NULL
,	NULL
giving	NULL
rise	NULL
to	NULL
an	NULL
altered	NULL
heterodimer	NULL
which	NULL
comigrates	NULL
with	NULL
the	NULL
p50	NULL
homodimer	NULL
(	NULL
6	NULL
)	NULL
.	NULL

This	NULL
cleavage	NULL
event	NULL
evidently	NULL
took	NULL
place	NULL
during	NULL
cell	NULL
extraction	NULL
,	NULL
as	NULL
this	NULL
complex	NULL
did	NULL
not	NULL
appear	NULL
if	NULL
particular	NULL
protease	NULL
inhibitors	NULL
(	NULL
chymostatin	NULL
,	NULL
3,4-dichloroisocouma-rin	NULL
,	NULL
diisopropyl	NULL
fluorophosphate	NULL
,	NULL
or	NULL
alpha	NULL
1l-antitrypsin	NULL
)	NULL
were	NULL
included	NULL
in	NULL
the	NULL
extraction	NULL
buffers	NULL
.	NULL

The	NULL
p50	NULL
homodimer	NULL
we	NULL
observed	NULL
was	NULL
clearly	NULL
not	NULL
the	NULL
aberrant	NULL
p50/p65	NULL
heterodimer	NULL
described	NULL
by	NULL
Franzoso	NULL
et	NULL
al	NULL
.	NULL

(	NULL
6	NULL
)	NULL
.	NULL

In	NULL
our	NULL
work	NULL
,	NULL
having	NULL
chymostatin	NULL
present	NULL
during	NULL
cell	NULL
extraction	NULL
did	NULL
not	NULL
eliminate	NULL
the	NULL
p50	NULL
homodimer	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
anti-p65	NULL
we	NULL
used	NULL
was	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
raised	NULL
against	NULL
a	NULL
peptide	NULL
corresponding	NULL
to	NULL
amino	NULL
acids	NULL
3	NULL
to	NULL
19	NULL
,	NULL
within	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
p65	NULL
;	NULL
this	NULL
antibody	NULL
failed	NULL
to	NULL
shift	NULL
the	NULL
fast-migrating	NULL
complex	NULL
.	NULL

We	NULL
did	NULL
,	NULL
however	NULL
,	NULL
see	NULL
evidence	NULL
of	NULL
a	NULL
truncated	NULL
complex	NULL
in	NULL
one	NULL
nuclear	NULL
extract	NULL
from	NULL
AMs	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Griffin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
)	NULL
analyzed	NULL
NF-kB	NULL
in	NULL
monocytes	NULL
,	NULL
adherent	NULL
macrophages	NULL
,	NULL
and	NULL
mouse	NULL
peritoneal	NULL
macrophages	NULL
and	NULL
found	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
constitutively	NULL
expressed	NULL
in	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

However	NULL
,	NULL
the	NULL
age	NULL
and	NULL
mode	NULL
of	NULL
purification	NULL
of	NULL
the	NULL
cells	NULL
J.	NULL
ViRoL	NULL
.	NULL

were	NULL
not	NULL
specified	NULL
,	NULL
and	NULL
supershift	NULL
assays	NULL
to	NULL
determine	NULL
the	NULL
constituents	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
xB	NULL
complex	NULL
were	NULL
not	NULL
performed	NULL
.	NULL

Suzan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
40	NULL
)	NULL
describe	NULL
clear	NULL
differences	NULL
in	NULL
the	NULL
NF-kB	NULL
subunits	NULL
expressed	NULL
in	NULL
uninfected	NULL
and	NULL
HIV-infected	NULL
monocytes	NULL
and	NULL
macrophages	NULL
,	NULL
but	NULL
the	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
cells	NULL
cultured	NULL
for	NULL
at	NULL
least	NULL
3	NULL
days	NULL
,	NULL
at	NULL
a	NULL
time	NULL
when	NULL
our	NULL
data	NULL
show	NULL
a	NULL
predominance	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
.	NULL

Differences	NULL
in	NULL
reported	NULL
constitutive	NULL
expression	NULL
of	NULL
NF-KB	NULL
in	NULL
primary	NULL
monocytes	NULL
have	NULL
been	NULL
attributed	NULL
to	NULL
mode	NULL
of	NULL
purification	NULL
and	NULL
culture	NULL
conditions	NULL
(	NULL
33	NULL
,	NULL
40	NULL
)	NULL
.	NULL

In	NULL
light	NULL
of	NULL
the	NULL
finding	NULL
that	NULL
expression	NULL
of	NULL
IkxBa	NULL
(	NULL
MAD-3	NULL
)	NULL
is	NULL
induced	NULL
within	NULL
30	NULL
min	NULL
of	NULL
monocyte	NULL
adherence	NULL
to	NULL
plastic	NULL
(	NULL
11	NULL
)	NULL
,	NULL
we	NULL
prepared	NULL
monocytes	NULL
by	NULL
adherence	NULL
and	NULL
also	NULL
by	NULL
immunomagnetic	NULL
bead	NULL
negative	NULL
selection	NULL
(	NULL
to	NULL
ensure	NULL
minimal	NULL
activation	NULL
)	NULL
and	NULL
found	NULL
similar	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
p50	NULL
homodimer	NULL
in	NULL
fresh	NULL
monocytes	NULL
prepared	NULL
either	NULL
way	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Our	NULL
finding	NULL
of	NULL
constitutive	NULL
expression	NULL
of	NULL
p50/p65	NULL
and	NULL
p50/	NULL
ReIB	NULL
in	NULL
AMs	NULL
is	NULL
the	NULL
first	NULL
direct	NULL
demonstration	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
in	NULL
primary	NULL
human	NULL
macrophages	NULL
and	NULL
is	NULL
consistent	NULL
with	NULL
data	NULL
from	NULL
mouse	NULL
peritoneal	NULL
macrophages	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
functional	NULL
significance	NULL
of	NULL
NF-kB-activated	NULL
transcription	NULL
in	NULL
the	NULL
HIV	NULL
life	NULL
cycle	NULL
is	NULL
controversial	NULL
.	NULL

The	NULL
single	NULL
NF-KB	NULL
site	NULL
of	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
SIV	NULL
nce	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
efficient	NULL
replication	NULL
of	NULL
SIV	NULL
mace	NULL
,	NULL
,	NULL
in	NULL
macaque	NULL
AMs	NULL
but	NULL
not	NULL
in	NULL
macaque	NULL
PBLs	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
NF-B	NULL
sites	NULL
of	NULL
HIV-1	NULL
are	NULL
a	NULL
critical	NULL
activator	NULL
of	NULL
transcription	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
when	NULL
assessed	NULL
by	NULL
an	NULL
HIV	NULL
LTR-CAT	NULL
expression	NULL
vector	NULL
(	NULL
10	NULL
,	NULL
21	NULL
)	NULL
,	NULL
their	NULL
importance	NULL
for	NULL
replication	NULL
of	NULL
HIV	NULL
in	NULL
differentiated	NULL
macrophages	NULL
is	NULL
un-known	NULL
.	NULL

However	NULL
,	NULL
constitutive	NULL
expression	NULL
of	NULL
p50/p65	NULL
and	NULL
p50/	NULL
RelB	NULL
would	NULL
clearly	NULL
favor	NULL
productive	NULL
HIV	NULL
replication	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
in	NULL
vivo	NULL
HIV	NULL
viral	NULL
load	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
AMs	NULL
produce	NULL
infectious	NULL
virus	NULL
more	NULL
frequently	NULL
than	NULL
circulating	NULL
monocytes	NULL
(	NULL
37	NULL
)	NULL
.	NULL

HIV	NULL
infection	NULL
induces	NULL
sustained	NULL
NF-kB	NULL
binding	NULL
activity	NULL
in	NULL
certain	NULL
HIV-infected	NULL
monocytic	NULL
cell	NULL
lines	NULL
(	NULL
1	NULL
,	NULL
25	NULL
,	NULL
29	NULL
,	NULL
31	NULL
,	NULL
32	NULL
,	NULL
40	NULL
)	NULL
and	NULL
in	NULL
MDMs	NULL
(	NULL
20	NULL
,	NULL
40	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
monocytic	NULL
cell	NULL
lines	NULL
and	NULL
MDMs	NULL
,	NULL
no	NULL
change	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
demonstrated	NULL
following	NULL
exposure	NULL
of	NULL
fresh	NULL
monocytes	NULL
to	NULL
HIV	NULL
.	NULL

The	NULL
failure	NULL
of	NULL
HIV	NULL
to	NULL
induce	NULL
pS50/p65	NULL
in	NULL
fresh	NULL
monocytes	NULL
may	NULL
be	NULL
due	NULL
simply	NULL
to	NULL
a	NULL
block	NULL
prior	NULL
to	NULL
reverse	NULL
transcription	NULL
as	NULL
recently	NULL
demonstrated	NULL
(	NULL
38	NULL
)	NULL
.	NULL

However	NULL
,	NULL
binding	NULL
alone	NULL
without	NULL
entry	NULL
and	NULL
reverse	NULL
transcription	NULL
may	NULL
be	NULL
sufficient	NULL
to	NULL
induce	NULL
NF-kB	NULL
,	NULL
since	NULL
induction	NULL
of	NULL
can	NULL
be	NULL
inhibited	NULL
in	NULL
CD4*	NULL
T	NULL
cells	NULL
by	NULL
CD4	NULL
ligands	NULL
such	NULL
as	NULL
CD4	NULL
antibodies	NULL
or	NULL
gp120	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Although	NULL
a	NULL
previous	NULL
study	NULL
has	NULL
shown	NULL
a	NULL
block	NULL
to	NULL
HIV	NULL
infection	NULL
of	NULL
fresh	NULL
monocytes	NULL
(	NULL
38	NULL
)	NULL
,	NULL
virus	NULL
binding	NULL
almost	NULL
certainly	NULL
occurs	NULL
(	NULL
as	NULL
there	NULL
is	NULL
abundant	NULL
surface	NULL
CD4	NULL
)	NULL
,	NULL
and	NULL
other	NULL
groups	NULL
have	NULL
demonstrated	NULL
entry	NULL
and	NULL
reverse	NULL
transcription	NULL
(	NULL
15	NULL
,	NULL
30	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Productive	NULL
HIV	NULL
infection	NULL
of	NULL
fresh	NULL
monocytes	NULL
may	NULL
appear	NULL
to	NULL
occur	NULL
if	NULL
the	NULL
virus	NULL
inoculum	NULL
is	NULL
allowed	NULL
to	NULL
persist	NULL
beyond	NULL
24	NULL
h	NULL
,	NULL
at	NULL
which	NULL
time	NULL
entry	NULL
and	NULL
reverse	NULL
transcription	NULL
can	NULL
occur	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
this	NULL
by	NULL
infecting	NULL
fresh	NULL
monocytes	NULL
with	NULL
HIV	NULL
and	NULL
then	NULL
culturing	NULL
them	NULL
for	NULL
14	NULL
days	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
recombinant	NULL
soluble	NULL
CD4	NULL
.	NULL

The	NULL
late	NULL
rise	NULL
in	NULL
supernatant	NULL
p24	NULL
antigen	NULL
which	NULL
occasionally	NULL
occurs	NULL
in	NULL
untreated	NULL
monocytes	NULL
was	NULL
completely	NULL
inhibited	NULL
by	NULL
recombinant	NULL
soluble	NULL
CD4	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
heretofore	NULL
unrecognized	NULL
differences	NULL
in	NULL
constitutive	NULL
and	NULL
inducible	NULL
expression	NULL
of	NULL
NF-kB	NULL
in	NULL
primary	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

These	NULL
differences	NULL
may	NULL
be	NULL
partially	NULL
responsible	NULL
for	NULL
the	NULL
relative	NULL
permissiveness	NULL
of	NULL
monocytes	NULL
and	NULL
macrophages	NULL
to	NULL
HIV	NULL
infection	NULL
in	NULL
vitro	NULL
and	NULL
the	NULL
different	NULL
transcriptional	NULL
activities	NULL
of	NULL
these	NULL
cell	NULL
populations	NULL
in	NULL
vivo	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
S.R.L	NULL
.	NULL

is	NULL
a	NULL
recipient	NULL
of	NULL
a	NULL
National	NULL
Health	NULL
and	NULL
Medical	NULL
Research	NULL
Council	NULL
Postgraduate	NULL
Medical	NULL
Scholarship	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
in	NULL
part	NULL
by	NULL
funding	NULL
from	NULL
the	NULL
National	NULL
Centre	NULL
in	NULL
HIV	NULL
Virology	NULL
and	NULL
the	NULL
Research	NULL
Fund	NULL
of	NULL
the	NULL
Macfarlane	NULL
Burnet	NULL
Centre	NULL
for	NULL
Medical	NULL
Re-search	NULL
.	NULL

We	NULL
thank	NULL
Heddy	NULL
Zola	NULL
from	NULL
Flinders	NULL
Medical	NULL
School	NULL
,	NULL
Adelaide	NULL
,	NULL
Australia	NULL
for	NULL
hybridoma	NULL
FMC63	NULL
;	NULL
Melissa	NULL
Churchill	NULL
and	NULL
Anna	NULL
Peeters	NULL
,	NULL
Macfarlane	NULL
Burnet	NULL
Centre	NULL
for	NULL
Medical	NULL
Research	NULL
for	NULL
the	NULL
oligonucleo-tides	NULL
;	NULL
Lou	NULL
Irving	NULL
from	NULL
Austin	NULL
Repatriation	NULL
Medical	NULL
Centre	NULL
for	NULL
the	NULL
bronchoalveolar	NULL
lavage	NULL
samples	NULL
,	NULL
and	NULL
Paul	NULL
Cameron	NULL
for	NULL
critical	NULL
evaluation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
.	NULL

Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1991	NULL
.	NULL

HIV	NULL
enhancer	NULL
activity	NULL
perpetuated	NULL
by	NULL
NF-kB	NULL
induction	NULL
on	NULL
infection	NULL
of	NULL
monocytes	NULL
.	NULL

Nature	NULL
350:709-712.	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141-179.	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
,	NULL
E.	NULL
Dixon	NULL
,	NULL
N.	NULL
Peffer	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
and	NULL
W.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
65-kDa	NULL
subunit	NULL
of	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
and	NULL
a	NULL
target	NULL
for	NULL
v-Rel-mediated	NULL
repression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1875-1879.	NULL
.	NULL

Bellas	NULL
,	NULL
R.	NULL
,	NULL
N.	NULL
Hopkins	NULL
,	NULL
and	NULL
Y.	NULL
Li	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NF-kB	NULL
binding	NULL
site	NULL
is	NULL
necessary	NULL
for	NULL
efficient	NULL
replication	NULL
of	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
of	NULL
macaques	NULL
in	NULL
primary	NULL
alveolar	NULL
macrophages	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:2908-2913	NULL
.	NULL

4a.Churchill	NULL
,	NULL
M.	NULL
Personal	NULL
communication	NULL
.	NULL

5	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

Crowe	NULL
,	NULL
S.	NULL
,	NULL
J	NULL
.	NULL

Mills	NULL
,	NULL
M.	NULL
McGrath	NULL
,	NULL
P.	NULL
Lekas	NULL
,	NULL
and	NULL
N.	NULL
McManus	NULL
.	NULL

1987	NULL
.	NULL

Quantitative	NULL
immunocytofluorographic	NULL
analysis	NULL
of	NULL
CD4	NULL
surface	NULL
antigen	NULL
expression	NULL
and	NULL
HIV	NULL
infection	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
monocyte/macrophages	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
3:135-145.	NULL
.	NULL

Franzoso	NULL
,	NULL
G.	NULL
,	NULL
P.	NULL
Biswas	NULL
,	NULL
G.	NULL
Poli	NULL
,	NULL
L.	NULL
Carlson	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
M.	NULL
Tomita-Yamagu-	NULL
chi	NULL
,	NULL
A.	NULL
Fauci	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
family	NULL
of	NULL
serine	NULL
proteases	NULL
expressed	NULL
in	NULL
myelo-monocytic	NULL
cells	NULL
specifically	NULL
processes	NULL
the	NULL
nuclear	NULL
factor-xB	NULL
subunit	NULL
p65	NULL
in	NULL
vitro	NULL
and	NULL
may	NULL
impair	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1445-1456.	NULL
.	NULL

Franzoso	NULL
,	NULL
G.	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
V.	NULL
Azarenko	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
M.	NULL
Tomita-Yamaguchi	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
oncoprotein	NULL
Bcl-3	NULL
can	NULL
facilitate	NULL
NF-	NULL
«	NULL
B-mediated	NULL
transactivation	NULL
by	NULL
removing	NULL
inhibiting	NULL
p50	NULL
homodimers	NULL
from	NULL
select	NULL
B	NULL
sites	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3893-3901.	NULL
.	NULL

Franzoso	NULL
,	NULL
G.	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
M.	NULL
Tomita-Yamaguchi	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
candidate	NULL
oncoprotein	NULL
Bel-3	NULL
is	NULL
an	NULL
antagonist	NULL
of	NULL
p50/	NULL
NF-	NULL
«	NULL
B-mediated	NULL
inhibition	NULL
.	NULL

Nature	NULL
359:339-342.	NULL
.	NULL

Gartner	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
Markovits	NULL
,	NULL
D.	NULL
M.	NULL
Markovitz	NULL
,	NULL
M.	NULL
H.	NULL
Kaplan	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
M.	NULL
Popovie	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
role	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
in	NULL
HTLV-III/LAV	NULL
infection	NULL
.	NULL

Science	NULL
233:215-219	NULL
.	NULL

Griffin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
T.	NULL
M.	NULL
Folks	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
339:70-73	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Beg	NULL
,	NULL
S.	NULL
Tompkins	NULL
,	NULL
J.	NULL
Morris	NULL
,	NULL
A.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
Baldwin	NULL
.	NULL

1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
by	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281-1289	NULL
.	NULL

Hazan	NULL
,	NULL
U.	NULL
,	NULL
D.	NULL
Thomas	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
N.	NULL
Israel	NULL
,	NULL
H.	NULL
Yssel	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
and	NULL
F.	NULL
Arenzana-Seisdedos	NULL
.	NULL

1990	NULL
.	NULL

Stimulation	NULL
of	NULL
a	NULL
human	NULL
T-cell	NULL
clone	NULL
with	NULL
anti-CD3	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
but	NULL
not	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
enhancer-dependent	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:7861-7865	NULL
.	NULL

Jabado	NULL
,	NULL
N.	NULL
,	NULL
F.	NULL
Le-Deist	NULL
,	NULL
A.	NULL
Fisher	NULL
,	NULL
and	NULL
C.	NULL
Hivroz	NULL
.	NULL

1994	NULL
.	NULL

Interaction	NULL
of	NULL
HIV	NULL
gp120	NULL
and	NULL
anti-CD4	NULL
antibodies	NULL
with	NULL
the	NULL
CD4	NULL
molecule	NULL
on	NULL
human	NULL
CD4+	NULL
T	NULL
cells	NULL
inhibits	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
NF-AT	NULL
,	NULL
NF-kappa	NULL
B	NULL
and	NULL
AP-1	NULL
,	NULL
three	NULL
nuclear	NULL
factors	NULL
regulating	NULL
interleukin-1	NULL
gene	NULL
enhancer	NULL
activity	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24:2646-2652	NULL
.	NULL

Kalter	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Nakamura	NULL
,	NULL
J.	NULL
Turpin	NULL
,	NULL
M.	NULL
Baca	NULL
,	NULL
D.	NULL
Hoover	NULL
,	NULL
C.	NULL
Dieffenbach	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
H.	NULL
Gendelman	NULL
,	NULL
and	NULL
M.	NULL
Meltzer	NULL
.	NULL

1991	NULL
.	NULL

Enhanced	NULL
HIV	NULL
replication	NULL
in	NULL
macrophage	NULL
colony	NULL
stimulatory	NULL
factor	NULL
treated	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146	NULL
:	NULL
298-306	NULL
.	NULL

Kazazi	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Mathijs	NULL
,	NULL
P.	NULL
Foley	NULL
,	NULL
and	NULL
A.	NULL
L.	NULL
Cunningham	NULL
.	NULL

1989	NULL
.	NULL

Variations	NULL
in	NULL
CD4	NULL
expression	NULL
by	NULL
human	NULL
monocytes	NULL
and	NULL
macrophages	NULL
and	NULL
their	NULL
relationship	NULL
to	NULL
infection	NULL
with	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

70:2661-2672	NULL
.	NULL

Koenig	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Gendelman	NULL
,	NULL
J.	NULL
Orenstein	NULL
,	NULL
M.	NULL
Dal	NULL
Canto	NULL
,	NULL
G.	NULL
Pezeshkpour	NULL
,	NULL
M.	NULL
Yungbluth	NULL
,	NULL
F.	NULL
Janotta	NULL
,	NULL
A.	NULL
Aksamit	NULL
,	NULL
M.	NULL
Martin	NULL
,	NULL
and	NULL
A.	NULL
Fauci	NULL
.	NULL

1986	NULL
.	NULL

Detection	NULL
of	NULL
AIDS	NULL
virus	NULL
in	NULL
macrophages	NULL
in	NULL
brain	NULL
tissue	NULL
from	NULL
AIDS	NULL
patients	NULL
with	NULL
encephalopathy	NULL
.	NULL

Science	NULL
233:1089-1093	NULL
.	NULL

Koyanagi	NULL
,	NULL
Y.	NULL
,	NULL
W.	NULL
O'Brien	NULL
,	NULL
J.	NULL
Zhao	NULL
,	NULL
D.	NULL
Golde	NULL
,	NULL
J.	NULL
Gasson	NULL
,	NULL
and	NULL
I.	NULL
Chen	NULL
.	NULL

1988	NULL
.	NULL

Cytokines	NULL
alter	NULL
production	NULL
of	NULL
HIV-1	NULL
from	NULL
primary	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

Science	NULL
241:1673-1675	NULL
.	NULL

Lee	NULL
,	NULL
T.-H.	NULL
,	NULL
F.	NULL
Sunzeri	NULL
,	NULL
L.	NULL
Tobler	NULL
,	NULL
B.	NULL
Williams	NULL
,	NULL
and	NULL
M.	NULL
Busch	NULL
.	NULL

1991	NULL
.	NULL

Quantitative	NULL
assessment	NULL
of	NULL
HIV-1	NULL
DNA	NULL
load	NULL
by	NULL
coamplification	NULL
of	NULL
HIV-1	NULL
gag	NULL
and	NULL
HLA-DQ	NULL
genes	NULL
.	NULL

AIDS	NULL
5:683-691	NULL
.	NULL

Lewin	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Sonza	NULL
,	NULL
L.	NULL
Irving	NULL
,	NULL
C.	NULL
McDonald	NULL
,	NULL
J	NULL
.	NULL

Mills	NULL
,	NULL
and	NULL
S.	NULL
Crowe	NULL
.	NULL

1996	NULL
.	NULL

EXPRESSION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
IN	NULL
FRESH	NULL
MONOCYTES	NULL
AND	NULL
MACROPHAGES	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

2119	NULL
Low	NULL
levels	NULL
of	NULL
surface	NULL
CD4	NULL
are	NULL
critical	NULL
for	NULL
HIV-1	NULL
in	NULL
vitro	NULL
infection	NULL
of	NULL
alveolar	NULL
macrophages	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retrovirus	NULL
12:877-883	NULL
.	NULL

McElhinny	NULL
,	NULL
J.	NULL
,	NULL
W.	NULL
MacMorran	NULL
,	NULL
G.	NULL
Bren	NULL
,	NULL
R.	NULL
Ten	NULL
,	NULL
A.	NULL
Israel	NULL
,	NULL
and	NULL
C.	NULL
Paya	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
IxBa	NULL
and	NULL
p105	NULL
in	NULL
monocytes	NULL
and	NULL
macrophages	NULL
persistently	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:1500-1509	NULL
.	NULL

Moses	NULL
,	NULL
A.	NULL
V.	NULL
,	NULL
C.	NULL
Ibanez	NULL
,	NULL
R.	NULL
Gaynor	NULL
,	NULL
P.	NULL
Ghazal	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Nelson	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
role	NULL
of	NULL
long	NULL
terminal	NULL
repeat	NULL
control	NULL
elements	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
basal	NULL
and	NULL
Tat-mediated	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
primary	NULL
human	NULL
macrophages	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:298-307	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
326	NULL
:	NULL
711-713	NULL
.	NULL

Oakes	NULL
,	NULL
J.	NULL
,	NULL
O.	NULL
Bagasra	NULL
,	NULL
L.	NULL
Duan	NULL
,	NULL
and	NULL
R.	NULL
Pomerantz	NULL
.	NULL

1994	NULL
.	NULL

Association	NULL
of	NULL
alterations	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
moicties	NULL
with	NULL
HIV	NULL
type	NULL
1	NULL
proviral	NULL
latency	NULL
in	NULL
certain	NULL
monocytic	NULL
cells	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
10:1213-1219	NULL
.	NULL

Olafsson	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
S.	NULL
Smith	NULL
,	NULL
P.	NULL
Marshburn	NULL
,	NULL
S.	NULL
G.	NULL
Carter	NULL
,	NULL
and	NULL
S.	NULL
Haskill	NULL
.	NULL

1991	NULL
.	NULL

Variation	NULL
of	NULL
HIV	NULL
infectibility	NULL
of	NULL
macrophages	NULL
as	NULL
a	NULL
function	NULL
of	NULL
donor	NULL
,	NULL
state	NULL
of	NULL
differentiation	NULL
,	NULL
and	NULL
site	NULL
of	NULL
origin	NULL
.	NULL

J	NULL
.	NULL

Acquired	NULL
Immune	NULL
Defic	NULL
.	NULL

Syndr	NULL
.	NULL

4:154-164.	NULL
.	NULL

Paya	NULL
,	NULL
C.	NULL
,	NULL
R.	NULL
Ten	NULL
,	NULL
C.	NULL
Bessia	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
R.	NULL
Hay	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1992	NULL
.	NULL

NF-	NULL
«	NULL
B-dependent	NULL
induction	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
subunit	NULL
gene	NULL
promoter	NULL
underlies	NULL
self-perpetuation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7826-7830	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
,	NULL
R.	NULL
Schmid	NULL
,	NULL
C.	NULL
Duckett	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
N.	NULL
Rice	NULL
,	NULL
and	NULL
G.	NULL
Nabel	NULL
.	NULL

1992	NULL
.	NULL

Distinct	NULL
combinations	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1529-1533	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Kinter	NULL
,	NULL
and	NULL
A.	NULL
Fauci	NULL
.	NULL

1994	NULL
.	NULL

Interleukin	NULL
1	NULL
induces	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
alone	NULL
and	NULL
in	NULL
synergy	NULL
with	NULL
interleukin	NULL
6	NULL
in	NULL
chronically	NULL
infected	NULL
U1	NULL
cells	NULL
:	NULL
inhibition	NULL
of	NULL
inductive	NULL
effects	NULL
by	NULL
the	NULL
interleukin	NULL
1	NULL
receptor	NULL
antagonist	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:108-112	NULL
.	NULL

Pomerantz	NULL
,	NULL
R.	NULL
,	NULL
M.	NULL
Feinberg	NULL
,	NULL
D.	NULL
Trono	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Lipopoly-saccharide	NULL
is	NULL
a	NULL
potent	NULL
monocyte/macrophage-specific	NULL
stimulator	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
expression	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:253-261	NULL
.	NULL

Raziuddin	NULL
,	NULL
J.	NULL
Mikovitz	NULL
,	NULL
I.	NULL
Calvert	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.-F.	NULL
Kung	NULL
,	NULL
and	NULL
F.	NULL
Ruscetti	NULL
.	NULL

1991	NULL
.	NULL

Negative	NULL
regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
expression	NULL
in	NULL
monocytes	NULL
:	NULL
role	NULL
of	NULL
the	NULL
65-kDa	NULL
plus	NULL
50-kDa	NULL
NF-	NULL
«	NULL
B	NULL
dimer	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
]	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:9426-9430	NULL
.	NULL

Rich	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
I	NULL
Chen	NULL
,	NULL
J.	NULL
Zack	NULL
,	NULL
M.	NULL
Leonard	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
O'Brien	NULL
.	NULL

1992	NULL
.	NULL

Increased	NULL
susceptibility	NULL
of	NULL
differentiated	NULL
mononuclear	NULL
phagocytes	NULL
to	NULL
productive	NULL
infection	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus-1	NULL
(	NULL
HIV-1	NULL
)	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

89:176-183	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Beauparlant	NULL
,	NULL
N.	NULL
Rice	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1993	NULL
.	NULL

Chronic	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
stimulates	NULL
distinct	NULL
NF-	NULL
«	NULL
B/re/	NULL
DNA	NULL
binding	NULL
activities	NULL
in	NULL
myelomonoblastic	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:5235-5246	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
D'Addario	NULL
,	NULL
F.	NULL
Boulerice	NULL
,	NULL
S.	NULL
Caplan	NULL
,	NULL
M.	NULL
Wainberg	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1992	NULL
.	NULL

Induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
and	NULL
NF-	NULL
«	NULL
B-like	NULL
activities	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
infection	NULL
of	NULL
myelomonoblastic	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:751-763	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
Lin	NULL
,	NULL
P.	NULL
Beauparlant	NULL
,	NULL
M.	NULL
A.	NULL
Wainberg	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
and	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
myeloid	NULL
cells	NULL
by	NULL
NF-	NULL
«	NULL
B/Rel	NULL
transcription	NULL
factors	NULL
.	NULL

Microbiol	NULL
.	NULL

Rev	NULL
.	NULL

59:481-505	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
P.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
strong	NULL
transcription	NULL
activating	NULL
potential	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3805-3817	NULL
.	NULL

Schrier	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
McCutchan	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Wiley	NULL
.	NULL

1993	NULL
.	NULL

Mechanisms	NULL
of	NULL
immune	NULL
activation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
monocytes/macro-phages	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:5713-5720	NULL
.	NULL

Schuitemaker	NULL
,	NULL
H.	NULL
,	NULL
N.	NULL
Koostra	NULL
,	NULL
M.	NULL
Koppelman	NULL
,	NULL
S.	NULL
Bruistein	NULL
,	NULL
H.	NULL
Huisman	NULL
,	NULL
M.	NULL
Tersmette	NULL
,	NULL
and	NULL
F.	NULL
Miedma	NULL
.	NULL

1992	NULL
.	NULL

Proliferation	NULL
dependent	NULL
HIV-1	NULL
infection	NULL
of	NULL
monocytes	NULL
occurs	NULL
during	NULL
differentiation	NULL
into	NULL
macrophages	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

89:1154-1160	NULL
.	NULL

Sierra-Madero	NULL
,	NULL
J.	NULL
,	NULL
Z.	NULL
Toosi	NULL
,	NULL
D.	NULL
Hom	NULL
,	NULL
C.	NULL
Finegan	NULL
,	NULL
E.	NULL
Hoenig	NULL
,	NULL
and	NULL
E.	NULL
Rich	NULL
.	NULL

1994	NULL
.	NULL

Relationship	NULL
between	NULL
load	NULL
of	NULL
virus	NULL
in	NULL
alveolar	NULL
macrophages	NULL
from	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infected	NULL
persons	NULL
,	NULL
production	NULL
of	NULL
cytokines	NULL
and	NULL
clinical	NULL
status	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

169:18-27	NULL
.	NULL

Sonza	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Maerz	NULL
,	NULL
N.	NULL
Deacon	NULL
,	NULL
J.	NULL
Meanger	NULL
,	NULL
J	NULL
.	NULL

Mills	NULL
,	NULL
and	NULL
S.	NULL
Crowe	NULL
.	NULL

1996	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
replication	NULL
is	NULL
blocked	NULL
prior	NULL
to	NULL
reverse	NULL
transcription	NULL
and	NULL
integration	NULL
in	NULL
freshly	NULL
isolated	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:3863-3869	NULL
.	NULL

Sonza	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Maerz	NULL
,	NULL
S.	NULL
Uren	NULL
,	NULL
A.	NULL
Violo	NULL
,	NULL
S.	NULL
Hunter	NULL
,	NULL
W.	NULL
Boyle	NULL
,	NULL
and	NULL
S.	NULL
Crowe	NULL
.	NULL

1995	NULL
.	NULL

Susceptibility	NULL
of	NULL
human	NULL
monocytes	NULL
to	NULL
HIV	NULL
type	NULL
1	NULL
infection	NULL
in	NULL
vifro	NULL
is	NULL
not	NULL
dependent	NULL
on	NULL
their	NULL
level	NULL
of	NULL
CD4	NULL
expression	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
11:769-776	NULL
.	NULL

Suzan	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Salaun	NULL
,	NULL
C.	NULL
Neuveut	NULL
,	NULL
B.	NULL
Spire	NULL
,	NULL
I.	NULL
Hirsch	NULL
,	NULL
P.	NULL
Le	NULL
Bouteiller	NULL
,	NULL
G.	NULL
Querat	NULL
,	NULL
and	NULL
J.	NULL
Sire	NULL
.	NULL

1991	NULL
.	NULL

Induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
HIV	NULL
type	NULL
1	NULL
infection	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:377-383	NULL
.	NULL

Valentin	NULL
,	NULL
A.	NULL
,	NULL
A	NULL
.	NULL

Von	NULL
Gegerfelt	NULL
,	NULL
S.	NULL
Matsuda	NULL
,	NULL
K.	NULL
Nilsson	NULL
,	NULL
and	NULL
B.	NULL
Asjo	NULL
.	NULL

1991	NULL
.	NULL

In	NULL
vitro	NULL
maturation	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
and	NULL
susceptibility	NULL
to	NULL
HIV-1	NULL
infection	NULL
.	NULL

J	NULL
.	NULL

Acquired	NULL
Immune	NULL
Defic	NULL
.	NULL

Syndr	NULL
.	NULL

4:751-759	NULL
.	NULL

